Impact Factor Collection


Endocrine-Related Cancer journal impact factor graphic

Endocrine-Related Cancer’s 2020 Impact Factor has risen to 5.678, with the five-year measure now standing at 6.169.

This increase in Impact Factor reflects the high-quality research identified by the Editorial Board, their hard work to ensure the upmost quality, and strong leadership. The journal now ranks 30 out of 145 journals in the Endocrinology and Metabolism category, placing it in the top quartile of journals, and 74 out of 242 in the Oncology category.




Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Esben Andreas Carlsen et al.

Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis
Joakim Crona et al.

Exosomes increased angiogenesis in papillary thyroid cancer microenvironment
Feng Wu et al.

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer
Young Shin Song et al.

Novel circular RNA circNF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16
Zhe Wang et al.

DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop
Veronica Vella et al.

Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia
Florian Bösch et al.

Analysis of the immune landscape of small bowel neuroendocrine tumors
M Cives et al.

Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
Martin K Bakht et al.

PI3K/mTOR inhibition potentiates and extends palbociclib activity in anaplastic thyroid cancer
Kristen Wong et al.




French Endocrine Society Guidance on endocrine side effects of immunotherapy
F Castinetti et al.

Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
Neil Portman et al.

Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectivess
Lucieli Ceolin et al.

Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups
David Taïeb et al.

Role of chemokine receptors in thyroid cancer and immunotherapy
Francesca Coperchini et al.

Oxidative stress in thyroid carcinomas: biological and clinical significance
Rabii Ameziane El Hassani et al.

Clock genes and cancer development in particular in endocrine tissues
Anna Angelousi et al.

Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer
Matthew Saldana et al.

Mechanisms linking the renin-angiotensin system, obesity, and breast cancer
Fahmida Rasha et al.

Epigenetic changes in fibroblasts drive cancer metabolism and differentiation
Rajeev Mishra et al.